These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 2283649)
1. The role of ACE inhibitors in the management of hypertension. Ramsay LE; Yeo WW J Hum Hypertens; 1990 Oct; 4 Suppl 4():1-4; discussion 4-5. PubMed ID: 2283649 [TBL] [Abstract][Full Text] [Related]
2. [Angiotensin II antagonists versus ACE inhibitors in the treatment of raised blood pressure]. Andersen RS; Christensen S Ugeskr Laeger; 2001 Dec; 163(50):7036-9. PubMed ID: 11794033 [TBL] [Abstract][Full Text] [Related]
3. [Effects of angiotensin-converting enzyme inhibitors in hypertension]. Rahn KH Z Kardiol; 1988; 77 Suppl 3():69-71. PubMed ID: 2850690 [TBL] [Abstract][Full Text] [Related]
4. [The value of angiotensin-converting enzyme inhibitors in the treatment of hypertension]. Klaus D Z Kardiol; 1988; 77 Suppl 3():73-88. PubMed ID: 3062960 [TBL] [Abstract][Full Text] [Related]
5. RAS inhibition in hypertension. Ibrahim MM J Hum Hypertens; 2006 Feb; 20(2):101-8. PubMed ID: 16397519 [TBL] [Abstract][Full Text] [Related]
6. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs. Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973 [TBL] [Abstract][Full Text] [Related]
7. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy. Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C; Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142 [TBL] [Abstract][Full Text] [Related]
8. [Are all antihypertensive drugs renoprotective?]. Wolf S; Risler T Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950 [TBL] [Abstract][Full Text] [Related]
9. [Angiotensin converting enzyme inhibitors for hypertension]. Kobusiak-Prokopowicz M Pol Merkur Lekarski; 1997 Jan; 2(7):66-70. PubMed ID: 9296907 [TBL] [Abstract][Full Text] [Related]
10. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertension due to primary aldosteronism: a case for exclusion. Bubbar CD; Blackburn DF; Wilson MP; Wilson TW Ann Pharmacother; 2007 Jan; 41(1):129-32. PubMed ID: 17179189 [TBL] [Abstract][Full Text] [Related]
12. Comparison of renin-angiotensin to calcium channel blockade in renal disease. Tikkanen I; Johnston CI Kidney Int Suppl; 1997 Dec; 63():S19-22. PubMed ID: 9407414 [TBL] [Abstract][Full Text] [Related]
13. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. Kjeldsen SE; Julius S Am Heart J; 2004 Nov; 148(5):747-54. PubMed ID: 15523303 [TBL] [Abstract][Full Text] [Related]
14. ACE inhibitors as initial therapy for hypertension. Schoenberger JA Am Fam Physician; 1988 Apr; 37(4):139-46. PubMed ID: 3282415 [TBL] [Abstract][Full Text] [Related]
15. Comparison of beta-blockade and ACE inhibitors in the treatment of hypertension. Prichard BN; Saul PA J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S81-5. PubMed ID: 11527141 [TBL] [Abstract][Full Text] [Related]
17. Treatment of hypertension from volume to vasoconstriction: The ACE up your sleeve. Stanley JC; Samson RH Semin Vasc Surg; 2002 Dec; 15(4):225-36. PubMed ID: 12478497 [TBL] [Abstract][Full Text] [Related]